Physician profile
Chris Cook
NPI 1215916242
$9,630.83
in general payments reported to CMS, 2019-2025
23 companies · $6,612 in 2025
The $6,612 reported for 2025 was more than what 86% of Thoracic Surgery (Cardiothoracic Vascular Surgery) providers received nationally (typical 2025 total: $796).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $133 · 2021: $106 · 2022: $732 · 2023: $1,007 · 2024: $1,041 · 2025: $6,612.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,623 · Travel and Lodging: $4,037.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,623.28 |
| Travel and Lodging | $4,036.59 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Atricure, INC. | $2,657.52 | 2024-2025 | Synergy Ablation System, Epi-Sense Guided Coagulation System With Visitrax, Atriclip Laa Exclusion System |
| Bolton Medical INC | $2,027.16 | 2025 | Treo Abdominal Stent-Graft System |
| Medtronic, INC. | $1,127.76 | 2022-2025 | Corevalve Evolut R, Endurant Iis, Avalus |
| Abbott Laboratories | $757.52 | 2023-2025 | Ensite Precision, Thoratec Heartmate 3 Lvas Implant Kit, Epic |
| Edwards Lifesciences Corporation | $568.40 | 2021-2025 | Sapien 3 Ultra Resilia, Thruport Systems Intraclude Intra-Aortic Occlusion Device, Inspiris Resilia Aortic Valve |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $553.80 | 2024-2025 | Lifevest |
| Stryker Corporation | $436.08 | 2019-2025 | Chromophare F300 |
| Abiomed | $257.97 | 2023-2025 | Impella |
| Kestra Medical Technology Services, INC. | $176.12 | 2025 | Assure Wcd |
| Baxter Healthcare | $163.63 | 2023-2024 | Coseal, Preveleak, Perclot |
| Smith+Nephew, INC. | $140.54 | 2024 | Pico 7, Acticoat 4" X 4" |
| Cerus Corporation | $119.48 | 2025 | Intercept Blood System For Platelets |
| Ethicon US, LLC | $113.03 | 2025 | Ethicon, Prolene |
| Penumbra, INC. | $91.06 | 2025 | Penumbra System |
| Boston Scientific Corporation | $90.90 | 2023 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cvrx, INC. | $72.39 | 2024 | Barostim Neo System |
| Mid-Atlantic Surgical Systems, LLC | $72.36 | 2025 | |
| Intuitive Surgical, INC. | $58.18 | 2023 | Da Vinci Surgical System |
| Teleflex LLC | $51.70 | 2024 | Manta |
| Getinge USA Sales, LLC | $48.72 | 2022-2025 | Vasoview Hemopro 2 |
| Kls-Martin L.P. | $20.20 | 2025 | |
| Almirall LLC | $13.88 | 2019 | |
| Siemens Medical Solutions USA, INC. | $12.43 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Chris Cook listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.